Condition: Alzheimer Disease · Sponsor: InSightec
The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Delray Medical Center & Florida Atlantic University | Delray Beach, Florida, United States | Recruiting |
| Broward Health Medical Center & The University of Florida | Fort Lauderdale, Florida, United States | Recruiting |
| University of Florida Health Shands | Gainesville, Florida, United States | Recruiting |
| Baptist Health South Florida & Florida International University | Miami, Florida, United States | Recruiting |
| Advent Health | Orlando, Florida, United States | Recruiting |
| Tampa General Hospital | Tampa, Florida, United States | Recruiting |
| Weill Cornell Medicine | New York, New York, United States | Active Not Recruiting |
| The Ohio State University -Wexner Medical Center | Columbus, Ohio, United States | Active Not Recruiting |
| University of Texas Southwestern Medical Center | Dallas, Texas, United States | Active Not Recruiting |
| West Virginia University Rockefeller Neuroscience Center | Morgantown, West Virginia, United States | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03671889